Xu, H.; Fang, B.; Bao, C.; Mao, X.; Zhu, C.; Ye, L.; Liu, Q.; Li, Y.; Du, C.; Qi, H.;
et al. The Prostaglandin E2 Receptor EP4 Promotes Vascular Neointimal Hyperplasia through Translational Control of Tenascin C via the cAMP/PKA/mTORC1/rpS6 Pathway. Cells 2022, 11, 2720.
https://doi.org/10.3390/cells11172720
AMA Style
Xu H, Fang B, Bao C, Mao X, Zhu C, Ye L, Liu Q, Li Y, Du C, Qi H,
et al. The Prostaglandin E2 Receptor EP4 Promotes Vascular Neointimal Hyperplasia through Translational Control of Tenascin C via the cAMP/PKA/mTORC1/rpS6 Pathway. Cells. 2022; 11(17):2720.
https://doi.org/10.3390/cells11172720
Chicago/Turabian Style
Xu, Hu, Bingying Fang, Chengzhen Bao, Xiuhui Mao, Chunhua Zhu, Lan Ye, Qian Liu, Yaqing Li, Chunxiu Du, Hang Qi,
and et al. 2022. "The Prostaglandin E2 Receptor EP4 Promotes Vascular Neointimal Hyperplasia through Translational Control of Tenascin C via the cAMP/PKA/mTORC1/rpS6 Pathway" Cells 11, no. 17: 2720.
https://doi.org/10.3390/cells11172720
APA Style
Xu, H., Fang, B., Bao, C., Mao, X., Zhu, C., Ye, L., Liu, Q., Li, Y., Du, C., Qi, H., Zhang, X., & Guan, Y.
(2022). The Prostaglandin E2 Receptor EP4 Promotes Vascular Neointimal Hyperplasia through Translational Control of Tenascin C via the cAMP/PKA/mTORC1/rpS6 Pathway. Cells, 11(17), 2720.
https://doi.org/10.3390/cells11172720